The Other Deadly AAA: Allergy, Angioedema, and Anaphylaxis - - PowerPoint PPT Presentation

the other deadly aaa allergy angioedema and anaphylaxis
SMART_READER_LITE
LIVE PREVIEW

The Other Deadly AAA: Allergy, Angioedema, and Anaphylaxis - - PowerPoint PPT Presentation

11/4/2013 The Other Deadly AAA: Allergy, Angioedema, and Anaphylaxis Disclosure No relevant financial interests H. Gene Hern, MD, MS, FACEP, FAAEM Assoc. Clinical Professor, UCSF Residency Director, Alameda County - Highland General


slide-1
SLIDE 1

11/4/2013 1

The Other Deadly AAA: Allergy, Angioedema, and Anaphylaxis

  • H. Gene Hern, MD, MS, FACEP, FAAEM
  • Assoc. Clinical Professor, UCSF

Residency Director, Alameda County - Highland General Oakland, California

Disclosure – No relevant financial

interests

A code is called in room 2

As you run down the hall pulling on your

gloves, you see a visitor unravel as she watches a 42 year old woman with two kids become unresponsive while she is talking to her

slide-2
SLIDE 2

11/4/2013 2

The patient recently rec’d some IM PCN

for her Strep Throat.

She is 240 lbs. Currently has no IV

access on she is flushed and warm.

As you push the curtains away and

begin to roll her into the code room you begin to ask yourself the following questions…

What is the best line to get on this

  • bese woman?

Do I need a line first? What dose of epi do I use? How can I give it?

Objectives

After this lecture you will: – Appreciate the spectrum of Allergic

reactions

– Recognize systemic and non-systemic

reactions

– Formulate your own strategy for dealing

with them

– Become a greater advocate for the

distribution of the Epi-Pen

Perspectives

What to do on a Cruise… 1902 Portier and Richet – Extract of jellyfish tentacles injected into a

dog

1st time tolerated 2nd time death (several weeks later.)

Anaphylaxis from Greek “against

protection”

(ana, against; phylax, guard or protect)

slide-3
SLIDE 3

11/4/2013 3

What does this tell us…

Early researchers had too much time on

their hands

It takes more than three weeks to cruise

the Mediterranean

Spectrum of Allergic reactions

Non-Systemic Systemic

Spectrum of Allergic reactions

Non-Systemic Systemic

Non-Systemic Allergic Reactions

Urticaria Angioedema

slide-4
SLIDE 4

11/4/2013 4

Non-Systemic Allergic Reactions

Urticaria Angioedema Case: 65 year old man calls 911 for lip

and tongue swelling

He is anxious and meets the ambulance

at the curb

He has a HTN and takes a BP med he

can’t remember

Urticaria and Angioedema

Effects up to 20% of population at some

point

Acute and Self-Limited – (some chronic forms exist) Similar pathological reaction in different

locations

slide-5
SLIDE 5

11/4/2013 5

Angioedema – Reaction deep in

dermis and Sub Q tissue.

– Non-Pruritic – Skin may appear

normal

– Face, Eyelids,

Tongue

slide-6
SLIDE 6

11/4/2013 6

slide-7
SLIDE 7

11/4/2013 7

Coexisting??

Urticaria and Angioedema co-exist in

many patients.

For unknown reasons: Some patients manifest urticaria (40%), Some angioedema (20%), Some both (40%)

Pathogenesis

Multiple mediators and Pathways – Allergen stimulation of IgE -> mast cell – Complement Cascade (C3a,4a,5a) -> mast

cells directly

– Hageman factor, via coagulation cascade,

induces formation of other mediators bradykinin and kallikrein

Etiology of Angioedema

Allergic Hereditary ACE Inhibitor related Unknown

Data from: Zingale LC, Beltrami L, Zanichelli A, et

  • al. Angioedema without urticaria: a large clinical
  • survey. CMAJ 2006; 175:1065.
slide-8
SLIDE 8

11/4/2013 8

Etiology - Hereditary

Associations with autoimmuine

disorders

SLE (7% of SLE pts. will develop hives/allergic

reactions)

Rheumatoid Arthritis

Truly Hereditary – HAE - Hereditary Angioedema – First described in 1876 (J.L. Milton)

HAE - Hereditary Angioedema

1:10000 pts. All races All sexes Recurrent attacks – 2-5 days in duration – Unresponsive to standard allergic therapy

Angioedema and ACE Inhibitors

The ACE Inhibitor issue Bradykinin response ACE (the actual enzyme) works on two

substrates

– Angiotensin I and Bradykinin By inhibiting ACE, Bradykinin levels

accumulate and cause Angioedema

Angioedema and ACE Inhibitors

Review of 108 cases of Angioedema 69% caused by ACE Inhibitor 30 min to 3 days of symptoms Single dose to 5 years Airway mgmt (intub. or cric) 13% – 50% of these were Diabetic

  • Chiu A.G., et al, Ann Otol Rhinol Laryngol 110(9):834,

September 2001

slide-9
SLIDE 9

11/4/2013 9

Urticaria and Angioedema - Treatment

First line

Anti-Histamines (H1 blockers)

  • Diphenhydramine

H2 blockers

  • Ranitidine, etc.
  • Studies for efficacy are small but do show

difference

Urticaria and Angioedema - Treatment

Steroids?? Probably… 43 pts. acute urticaria. – Much improved pruritis and rash at both 2

and 5 days. P<.0001

  • Pollack, C.V., et al, Ann Emerg Med 26(5):547,

Urticaria and Angioedema - Treatment

And gosh darn it… – Stop the ACE Inhibitor – Vanderbilt Study with 82 ACE I related

cases

Recurrence rate 18.7 per 100 person-yrs vs.

1.8 in pts, who didn’t stop taking meds

  • Brown, NJ, et al, JAMA 278(3):232, July 16,

1997

Urticaria and Angioedema - Treatment

What if it isn’t allergic????

  • Hered. Angio. With C1-Inh. Def.

– Give C1 esterase inhibitor concentrate

69% resolution in 30 min 95% resolution in 4 hours

  • Waytes AT, Rosen FS, Frank MM. N Engl J Med.

1996 Jun 20;334(25):1630-4.

– FFP

slide-10
SLIDE 10

11/4/2013 10

Urticaria and Angioedema - Treatment

Newer Treatments – Ecallantide - Blocks the pathway (Kallikrein

Inhibitor)

– Icatibant - Blocks the pathway (Bradykinin

B2 receptor antagonist)

J Am Acad Derm, Nov 2010 Ann Emerg Med, Sep 2010

– 8 patients. Mean time to sx improvement 51 min. Complete relief 4.4 hrs vs. 47 hx controls relief at 33 hrs

Urticaria and Angioedema - Treatment

Obviously advanced airway plans etc.

should treatment fail or should the patient decompensate…

Recent case from last month…

Urticaria and Angioedema - Treatment

Last Week…

slide-11
SLIDE 11

11/4/2013 11

An add’l tip for oxygenation

Can Achieve 20-30 LPM Temporizing

slide-12
SLIDE 12

11/4/2013 12

Spectrum of Allergic reactions

Non-Systemic Systemic

Spectrum of Allergic reactions

Non-Systemic Systemic

Systemic Allergic reactions - Anaphylaxis

First fatal anaphylaxis 4000 years ago -

Hymenoptera sting

– Currently, iatros more common than Hymenoptera Hymenoptera venom (yellow jackets, hornets,

honeybees, bumblebees, wasps)

50 deaths per year in the United States

  • far outnumbering deaths from snake bites

Only 9-25% of fatal stings report previous hymenoptera

allergy

Systemic Allergic reactions - Anaphylaxis

– Historic Iatros

Horse serum for DT(early) PCN - First fatality 1949

– Today -- 500 fatalities annually

radiocontrast dyes beta-lactam antibiotics

– 1-5 per 10,000 administrations – 10% of these are life-threatening – 1% are fatal. – Majority from IV or IM administrations rather than oral therapy

– Anaphylactic reactions to foods

shellfish, nuts (esp. peanuts), and eggs

slide-13
SLIDE 13

11/4/2013 13

Anaphylaxis - Pathophysiology

IgE mediated hypersensitivity reaction Similar to allergic rhinitis but more profound – Histamine and other pre-formed mediators – Overwhelming vascular permeability Anaphylactoid reactions (non IgE-mediated) – clinically indistinguishable from true anaphylaxis

Anaphylaxis - Onset of Symptoms

Most occur within seconds to minutes Few are asymptomatic for an hour and

THEN develop symptoms

Anaphylaxis - Duration of Symptoms

Most patients – Predictable - uniphasic course which resolves

with treatment

20% of patients - have BIPHASIC reactions – A second episode up to eight hours following

apparent recovery from the initial event

Rarely, symptoms may persist >1 day

Anaphylaxis - Duration of Symptoms

NO particular test or spectrum of clinical

symptoms predicts who will have biphasic or protracted responses

slide-14
SLIDE 14

11/4/2013 14

Anaphylaxis - Symptoms

Multi-System Spectrum – CV - HypoTN, Shock, CP, MI, Arrhythmias – RESP - Wheezing, Bronchospasm – Neuro - Anxiety, Confusion, Dizziness, SZ – Derm - Pruritis, Angioedema, Urticaria – GI - N/V, Diarrhea

Anaphylaxis – “New” definitions

1 – Acute onset of skin, mucosal tissue

and either

– Respiratory Compromise – Or – Reduced BP with end organ evidence 2nd Criteria Two or more of the following after

exposure to likely allergen

– Skin/mucosal inflammation – Resp. compromise – Reduced BP – Persistent GI symptoms (Vomiting, pain) 3rd Criteria Reduced BP after exposure to a

KNOWN allergen for that patient

– <90 mm HG or a drop of 30% from

baseline

– To detect reaction in patients with only 1

  • rgan system affected but clearly known to

be allergic (peanuts, bee stings)

slide-15
SLIDE 15

11/4/2013 15

Anaphylaxis - Causes of Death

Airway Obstruction Cardiovascular Collapse Target Therapies Accordingly

Anaphylaxis - Treatment

Consider Anaphylaxis as one end of an

Allergic spectrum

While it may share characteristics with

Angioedema, it is wise to think of them as the same identity (at least initially)

The initial treatment is the same

Anaphylaxis - Treatment

Preparation Make sure you know where your difficult

airway tools are

– Nasal vasoconstrictors – Cricothyrotomy kit – Fiberoptic Intubating Bronchoscope

Anaphylaxis - Treatment

Universal Initial Therapy Critical Care Room Get ALL the relevant Data ABC’s Vital Signs

slide-16
SLIDE 16

11/4/2013 16

Anaphylaxis - Treatment

First Line – Epinephrine (If IV, NEVER undiluted) – Fluids – Antihistamines (prob H1 and H2) Second Line – Steroids (may help with rebound

anaphylaxis)

– Glucagon? (theoretical benefit)

Anaphylaxis - Treatment

Epinephrine is the drug of choice for

treatment of systemic anaphylaxis

– Alpha - reverses peripheral vasodilation

Systolic and diastolic blood pressure Angioedema and urticaria

– Beta - bronchodilation, cardiac inotropy

and chronotropy

Anaphylaxis - Treatment - Side Effects

Epinephrine - associated with

DISASTROUS side-effects – esp if fast IV infusion

– Hypertensive crisis

causing cerebral hemorrhage, pulmonary

edema – Arrhythmias or myocardial infarction

Anaphylaxis - Treatment

Epinephrine - – IM/SQ epinephrine is recommended, even

with mild presentations, if truly anaphylactic

0.3 mg to IM/SQ q 15-20 minutes until

symptoms abate – A systolic blood pressure of 60 mmHg is

sufficient to absorb IM or SQ epinephrine

– IM actually works better -J All Clin Imm 2001

slide-17
SLIDE 17

11/4/2013 17

Anaphylaxis - Treatment

Airway obstruction Severe bronchospasm Hypotension ALL Require IV epinephrine !!!

Anaphylaxis - Treatment

The dose of IV epinephrine is

controversial

No studies have established a definitive

dose

– safe – therapeutic

Anaphylaxis - Treatment

Slow, low-dose infusion rates stimulate

beta-receptors more than alpha- receptors

– Bronchodilation and modest increase in

systolic blood pressure

Fast, high-dose infusions appear to

preferentially stimulate alpha-receptors

– causing severe hypertension, arryhthmias,

and myocardial ischemia

Anaphylaxis - Treatment

Epinephrine Drip Or How to give IV EPI and not kill my patient!!!

slide-18
SLIDE 18

11/4/2013 18

Anaphylaxis - Treatment

Epinephrine Drip Best Method. – 1 mg of epinephrine (code cart) in 1000 cc NS – to give a concentration of 1 mcg/cc 2-10 ml per minute IV PEDS patients, the infusion rate begins at 0.1

mcg/kg/min

DISPOSITION

Mild Anaphylaxis – OBSERVE 6-8 hours Anything but Mild – Admit for 24 hour monitoring for Biphasic

reaction

AND FINALLY….

ALL patients should receive a self-injectable

kit

– Epi-pen (0.3mg SQ) – Epi-pen, Jr. (0.15mg SQ) Instructed in its use 40% of children with hymenoptera allergy did

not receive an epinephrine prescription

  • Moffitt, Ann Allergy, 1992;68:81.

FINAL Take Home Points

Use Both H1 and H2 blockers (though

may not help in HAE or ACE AE)

Use Steroids (though may not help) Be PREPARED to get Surgical Airway Don’t EVER push undiluted EPI IV

slide-19
SLIDE 19

11/4/2013 19

A Return to our objectives…

Appreciate the spectrum of Allergic

reactions

Recognize systemic and non-systemic

reactions

Formulate your own strategy for dealing

with them

Become a greater advocate for the

distribution of the Epi-Pen

Thanks!!